You are here

Article info

Article menu
Download PDFPDF
Editorial
Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues

Authors

  • Robert F Storey Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK Directorate of Cardiology and Cardiothoracic Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Robert F Storey, Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield S10 2RX, UK; r.f.storey{at}sheffield.ac.uk
View Full Text

Citation

Storey RF
Ticagrelor versus prasugrel for PCI-managed myocardial infarction: the battle of the giants continues
Heart 2021;107:1111-1112.

Publication history

  • First published March 19, 2021.
Online issue publication 
June 29, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.